US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Apr 26, 2023 (3 years ago)

Fluticasone Propionate Nasal Spray

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Firm went out of business and could no longer continue stability studies.

What was recalled

Fluticasone Propionate Nasal Spray, 50mcg, 16 g bottles, Manufactured by: HI-TECH PHARMACAL CO., INC., Amiy. ALL NDCs

Recalling firm
Akorn, Inc.
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0804-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Fluticasone recalls

See all
Class II · Moderate risk Ongoing

Fluticasone Propionate Nasal Spray USP

Reason CGMP Deviations:Suspected potential presence of Burkholderia cepacia complex

Golden State Medical Supply Inc. NDC 60429-195-15 D-0349-2024
Class II · Moderate risk Terminated

Fluticasone Propionate Nasal Spray

Reason Defective container: defect prevents product from dispensing as intended.

Akorn, Inc. NDC 50383-700-16 D-1172-2022
Class II · Moderate risk Terminated

Inhub Wixela

Reason CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Cardinal Healthcare D-0202-2024
Class II · Moderate risk Terminated

Fluticasone Propionate Nasal Spray USP

Reason CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Cardinal Healthcare D-0182-2024